Ketamina asociada a terapia electroconvulsiva en depresión resistente al tratamiento en pacientes de edad avanzada: a propósito de 2 casos

Fortea, Adriana; Espinosa, Laura; Oliveras, Clara; Bruguera, Pol; Benabarre, Antoni.
Rev. psiquiatr. salud ment ; 10(2): 125-126, abr.-jun. 2017.
Artículo en Español | IBECS (España) | ID: ibc-162801

Documentos relacionados

  1. Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults.
  2. Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM): Study Design and Treatment Characteristics of the First 396 Participants Randomized.
  3. [Clinical management of treatment-resistant depression].
  4. Vascular risk factors in older patients with depression: outcome of electroconvulsive therapy versus medication.
  5. Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression.
  6. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
  7. Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.
  8. Is Venlafaxine More Effective than Escitalopram and Nortriptyline in the Management of Painful Symptoms in Patients with Major Depression?
  9. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials.
  10. Graphene-enhanced hybrid terahertz metasurface sensor for ultrasensitive nortriptyline sensing and detection.